Evidence map›Paper›PMID 32255569›Full record

ArticleThe Kaohsiung journal of medical sciences2020

MiR-129-5p alleviates myocardial injury by targeting suppressor of cytokine signaling 2 after ischemia/reperfusion.

Rui Ma, Xin Chen, Yue Ma, Gang Bai, Dong-Sheng Li

Open access · goldAbstract read
In one paragraph

Article in The Kaohsiung journal of medical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Rui MaDepartment of Geriatrics, National Pharmacy Dongfeng General Hospital, Shiyan, China.
Xin ChenDepartment of Geriatrics, National Pharmacy Dongfeng General Hospital, Shiyan, China.
Yue MaDepartment of Spine, National Pharmacy Dongfeng General Hospital, Shiyan, China.
Gang BaiDepartment of Ultrasonography, Tai He Hospital, Shiyan, China.
Dong-Sheng LiDepartment of Cardiology, Wuhan Third Hospital-Tongren Hospital of Wuhan University, Wuhan, China.ORCID https://orcid.org/0000-0002-5483-353X
Dongfeng General Hospital · CNTaihe Hospital · CNTongren Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute myocardial infarction (AMI) remains one of the leading causes of morbidity and mortality worldwide. Ischemia/reperfusion (I/R), the most common consequence of AMI treatment, may induce severe myocardial cell injury, yet the precise mechanism continues to be enigmatic. In the present study, we found that miR-129-5p was significantly downregulated in mouse I/R model. Then, we overexpressed miR-129-5p via intravenous injection of specific miR-129-5p agomir before I/R model establishment. MiR-129-5p overexpression dramatically alleviated myocardial injury in I/R mice as evidenced by reduced lactate dehydrogenase (LDH) activity, malondialdehyde (MDA) content, and infract size. We further detected the effect of miR-129-5p on hypoxia/reoxygenation (H/R)-induced H9C2 cell in vitro. MiR-129-5p overexpression improved H9C2 cell viability and inhibited cell apoptosis induced by H/R, accompanied with decreased LDH activity and MDA content. Besides, luciferase reporter assay indicated that suppressor of cytokine signaling 2 (SOCS2) was a downstream target of miR-129-5p. SOCS2 was upregulated in H/R induced H9C2 cells, and miR-129-5p overexpression suppressed SOCS2 expression at both mRNA and protein levels. In addition, SOCS2 overexpression abolished the protective effects of miR-129-5p on H/R-induced H9C2 cells, concomitant with elevated expression of apoptosis-related cleaved poly-(ADP-ribose) polymerase and cleaved caspase-3. In conclusion, our results demonstrated that miR-129-5p alleviated myocardial injury induced by I/R both in vitro and in vivo, and miR-129-5p/SOCS2 axis is a potential therapeutic target for alleviating myocardial injury in AMI patients after reperfusion.

Indexed as

AnimalsBase SequenceCell LineDisease Models, AnimalDown-RegulationMice, Inbred C57BLMicroRNAsMyocardial Reperfusion InjuryMyocardiumRatsSuppressor of Cytokine Signaling ProteinsMicroRNAsMIRN129 microRNA, mouseSocs2 protein, mouseSuppressor of Cytokine Signaling Proteinsischemia/reperfusionmiR-129-5pmyocardial injurySOCS2

Identifiers

PMID32255569
PMCPMC11896146
OpenAlexW3014638840

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.